Trial Profile
Randomised, Open-label, 3-way Crossover study to evaluate the 2 new Overencapsulated Tablet formulations (Formulation B and C) relative to an overencapsulated form of the early tablet (Formulation A) in Healthy male volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 01 Oct 2018
Price :
$35
*
At a glance
- Drugs Mavatrep (Primary)
- Indications Pain
- Focus Pharmacokinetics
- 01 Oct 2018 Results published in the Clinical Pharmacology in Drug Development
- 01 Oct 2018 New trial record